N-1-Benzenesulfonyl-5-methoxy-N,N-dimethyltryptamine (BS/5-OMe DMT; 5) was
shown to bind at human 5-HT6 serotonin receptors with high affinity (K-i =
2.3 nM) relative to serotonin (K-i = 78 nM). Structural variation failed to
result in significantly enhanced affinity. BS/5-OMe DMT acts as an antagon
ist of 5-HT-stimulated adenylate cyclase (pA(2) = 8.88 nM) and may represen
t the first member of a novel class of 5-HT6 antagonists. (C) 2000 Elsevier
Science Ltd. All rights reserved.